Page last updated: 2024-10-26

disulfiram and Medulloblastoma

disulfiram has been researched along with Medulloblastoma in 1 studies

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Serra, R1
Zhao, T1
Huq, S1
Gorelick, NL1
Casaos, J1
Cecia, A1
Mangraviti, A1
Eberhart, C1
Bai, R1
Olivi, A1
Brem, H1
Jackson, EM1
Tyler, B1

Other Studies

1 other study available for disulfiram and Medulloblastoma

ArticleYear
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Copper;

2021